Found: 19
Select item for more details and to access through your institution.
Discovery of proangiogenic CD44+mesenchymal cancer stem cells in an acute myeloid leukemia patient's bone marrow.
- Published in:
- 2020
- By:
- Publication type:
- Letter
FBP1-Altered Carbohydrate Metabolism Reduces Leukemic Viability through Activating P53 and Modulating the Mitochondrial Quality Control System In Vitro.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 19, p. 11387, doi. 10.3390/ijms231911387
- By:
- Publication type:
- Article
A phase 3 trial of armodafinil for the treatment of cancer-related fatigue for patients with multiple myeloma.
- Published in:
- Supportive Care in Cancer, 2015, v. 23, n. 6, p. 1503, doi. 10.1007/s00520-014-2486-7
- By:
- Publication type:
- Article
Phase II study of bortezomib in combination with rituximab, cyclophosphamide and prednisone with or without doxorubicin followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma.
- Published in:
- British Journal of Haematology, 2014, v. 166, n. 6, p. 920, doi. 10.1111/bjh.12991
- By:
- Publication type:
- Article
Akt-Induced Phosphorylation of N-CoR at Serine 1450 Contributes to Its Misfolded Conformational Dependent Loss (MCDL) in Acute Myeloid Leukemia of the M5 Subtype.
- Published in:
- PLoS ONE, 2013, v. 8, n. 8, p. 1, doi. 10.1371/journal.pone.0070891
- By:
- Publication type:
- Article
Determinants of Sensitivity to DZNep Induced Apoptosis in Multiple Myeloma Cells.
- Published in:
- PLoS ONE, 2011, v. 6, n. 6, p. 1, doi. 10.1371/journal.pone.0021583
- By:
- Publication type:
- Article
The Slow-Releasing Hydrogen Sulfide Donor, GYY4137, Exhibits Novel Anti-Cancer Effects In Vitro and In Vivo.
- Published in:
- PLoS ONE, 2011, v. 6, n. 6, p. 1, doi. 10.1371/journal.pone.0021077
- By:
- Publication type:
- Article
Analysis of Post-Transplant Lymphoproliferative Disorder (PTLD) Outcomes with Epstein–Barr Virus (EBV) Assessments—A Single Tertiary Referral Center Experience and Review of Literature.
- Published in:
- Cancers, 2021, v. 13, n. 4, p. 899, doi. 10.3390/cancers13040899
- By:
- Publication type:
- Article
Practices, Attitudes, and Beliefs Associated With Complementary and Alternative Medicine (CAM) Use Among Cancer Patients.
- Published in:
- Integrative Cancer Therapies, 2012, v. 11, n. 3, p. 232, doi. 10.1177/1534735411433832
- By:
- Publication type:
- Article
Incidence, risk factors, and mortality from pneumonia developing late after hematopoietic stem cell transplantation.
- Published in:
- Bone Marrow Transplantation, 2003, v. 32, n. 5, p. 515, doi. 10.1038/sj.bmt.1704162
- By:
- Publication type:
- Article
Differential remodeling of extracellular matrices by breast cancer initiating cells.
- Published in:
- Journal of Biophotonics, 2015, v. 8, n. 10, p. 804, doi. 10.1002/jbio.201400079
- By:
- Publication type:
- Article
The importance of vitamin d metabolism as a potential prophylactic, immunoregulatory and neuroprotective treatment for COVID-19.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Expression of the epigenetic factor BORIS (CTCFL) in the human genome.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Intravenous ascorbic acid to prevent and treat cancer-associated sepsis?
- Published in:
- 2011
- By:
- Publication type:
- journal article
Development of a Competitive Nutrient-Based T-Cell Immunotherapy Designed to Block the Adaptive Warburg Effect in Acute Myeloid Leukemia.
- Published in:
- Biomedicines, 2024, v. 12, n. 10, p. 2250, doi. 10.3390/biomedicines12102250
- By:
- Publication type:
- Article
Targeting the Tumor Microenvironment in Acute Myeloid Leukemia: The Future of Immunotherapy and Natural Products.
- Published in:
- Biomedicines, 2022, v. 10, n. 6, p. 1410, doi. 10.3390/biomedicines10061410
- By:
- Publication type:
- Article
Targeting TKI-Activated NFKB2-MIF/CXCLs-CXCR2 Signaling Pathways in FLT3 Mutated Acute Myeloid Leukemia Reduced Blast Viability.
- Published in:
- Biomedicines, 2022, v. 10, n. 5, p. 1038, doi. 10.3390/biomedicines10051038
- By:
- Publication type:
- Article
A modified regimen of pegylated liposomal doxorubicin, bortezomib and dexamethasone (DVD) is effective and well tolerated for previously untreated multiple myeloma patients.
- Published in:
- British Journal of Haematology, 2011, v. 155, n. 5, p. 580, doi. 10.1111/j.1365-2141.2011.08884.x
- By:
- Publication type:
- Article
Discovery of NFκB2-Coordinated Dual Regulation of Mitochondrial and Nuclear Genomes Leads to an Effective Therapy for Acute Myeloid Leukemia.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 15, p. 8532, doi. 10.3390/ijms25158532
- By:
- Publication type:
- Article